Genetic testing, adverse selection, and the demand for life insurance.

Abstract excerpt

The dramatic increase in genetic testing for adult-onset diseases has created a debate regarding whether or not insurance companies should be able to use genetic test results in underwriting. We use data from women who have been tested for the BRCA1 gene mutation along with data from otherwise comparable untested women to assess the potential for adverse selection in the life insurance market when tested...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adolescent
• Share to Breast Neoplasms
• Share to Demography